Life Science News: Late April 2026
EMERALD-3 liver cancer results, Eli Lilly's weight-loss pill approval, a $12B M&A wave, and what the CAR-T expansion means for oncology.
Life Science News: Mid-April 2026
The biggest life science stories from mid-April 2026: daraxonrasib doubles survival in pancreatic cancer, an oral GLP-1 pill approved, and what's coming next.
Life Science News: Early April 2026
Life science news for early April 2026: gene therapy approvals, the oral GLP-1 race, and in vivo CAR immune cell research from Science Translational Medicine.
Life Science News: Late March 2026
Key life science and biotech news for late March 2026 — in vivo CAR-T cells, retatrutide Phase 3 results, NIH foreign grant crackdown, and more.
Life Science Roundup: Tools, Funding, and Career News for March 2026
What changed in the last two weeks across life science tools, NIH funding, and the job market, with practical takeaways for your work.
Life Science & Biotech News: Week of March 9, 2026
Roche's oral SERD stumbles in Phase 3, EMBL's MAGIC AI flags early cancer, and Lilly's oral GLP-1 heads for approval. Your weekly research digest.
The NIH Funding Crisis: What Computational Biology Needs to Know
NIH indirect cost caps and budget pressures are reshaping research funding. Here's what postdocs and grad students should do now.
Bioinformatics Tools Worth Knowing About: Early 2026 Roundup
Notable updates to bioinformatics tools, platforms, and databases from late 2025 and early 2026 — and what they mean for your work.
AlphaFold 3: Structure Prediction Beyond Proteins
AlphaFold 3 predicts DNA, RNA, ligands, and protein complexes. Learn what changed, how it compares to alternatives, and when to use it.
CRISPR in the Clinic 2026: What the Latest Trial Results Tell Us
Clinical CRISPR progress in 2026. Casgevy data, Intellia's in vivo results, and what's next for gene editing.
Life Science News: February 2026 Highlights
February 2026 features Alzheimer's research momentum, T cell engineering advances, and AAAS meeting coverage for scientists.
Life Science News: What to Watch in Early 2026
January 2026 highlights JPMorgan Healthcare Conference, AI in drug discovery, and career outlook for scientists.
Computational Biology Papers That Mattered in 2025
Five papers from 2025 that changed computational biology: from long-read isoform atlases to trustworthy AI for drug discovery.
Life Science in 2025: The Year That Mattered
2025 shaped life science with AI in biology, GLP-1 momentum, and single-cell becoming standard. What defined the year.
What ASHG 2025 Revealed About AI and Genomics
ASHG 2025 showed how AI is transforming genomics. But the conference revealed uncomfortable truths about who benefits from precision medicine.
Life Science News: What Happened in October 2025
October 2025 wrapped regulatory T cell Nobel, GLP-1 momentum, and ASHG preview for life scientists.
Nobel Prize 2025: Why Regulatory T Cells Matter to Your Research
The 2025 Nobel Prize went to Sakaguchi, Brunkow, and Ramsdell for discovering regulatory T cells and FOXP3 — reshaping cancer immunotherapy and autoimmune research.
EMBL-EBI Launches BioAIrepo: A Central Hub for Life Science AI Models
EMBL-EBI launches BioAIrepo: a curated hub for AI models in protein structure, splicing, microscopy, and omics. What it means for your research.